AstraZeneca Pharma India passed two ordinary resolutions approving material related party transactions with AstraZeneca UK Limited and AstraZeneca AB, Sweden.
Both resolutions received ~83% votes in favour from non-promoter members, with promoter group (18.75 million shares) abstaining as interested parties.
E-voting ran from February 28 to March 29, 2026; 292 valid votes were cast out of 29,857 total shareholders on record date February 20, 2026.
Scrutinizer Vijayakrishna KT (FCS 1788) confirmed both resolutions passed with requisite majority via remote e-voting only.